HAC
ABBV icon

Harbor Advisory Corp’s AbbVie ABBV Stock Holding History

Harbor Advisory Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12M Sell
16,357
-345
-2% -$74.2K 1.1% 30
2026
Q1 		$3.63M Sell
16,702
-2,775
-14% -$616K 1.09% 31
2025
Q4 		$4.45M Sell
19,477
-2,400
-11% -$547K 1.35% 26
2025
Q3 		$5.07M Sell
21,877
-1,535
-7% -$313K 1.5% 23
2025
Q2 		$4.35M Sell
23,412
-118
-0.5% -$21.9K 1.38% 25
2025
Q1 		$4.93M Sell
23,530
-465
-2% -$90.4K 1.65% 22
2024
Q4 		$4.26M Sell
23,995
-150
-0.6% -$27.6K 1.4% 25
2024
Q3 		$4.77M Buy
24,145
+250
+1% +$46.7K 1.56% 24
2024
Q2 		$4.1M Sell
23,895
-1,603
-6% -$266K 1.42% 26
2024
Q1 		$4.64M Sell
25,498
-481
-2% -$82.9K 1.58% 23
2023
Q4 		$4.03M Sell
25,979
-650
-2% -$94.8K 1.44% 25
2023
Q3 		$3.97M Sell
26,629
-312
-1% -$45.8K 1.44% 24
2023
Q2 		$3.63M Sell
26,941
-117
-0.4% -$17.2K 1.28% 30
2023
Q1 		$4.31M Sell
27,058
-955
-3% -$146K 1.65% 23
2022
Q4 		$4.53M Buy
28,013
+760
+3% +$117K 1.85% 21
2022
Q3 		$3.66M Buy
27,253
+2,211
+9% +$317K 1.68% 25
2022
Q2 		$3.83M Buy
25,042
+667
+3% +$102K 1.68% 24
2022
Q1 		$3.95M Sell
24,375
-1,015
-4% -$147K 1.59% 26
2021
Q4 		$3.44M Buy
25,390
+10,682
+73% +$1.26M 1.39% 29
2021
Q3 		$1.59M Buy
14,708
+2,525
+21% +$289K 0.69% 41
2021
Q2 		$1.37M Buy
12,183
+7,700
+172% +$867K 0.62% 43
2021
Q1 		$485K Buy
4,483
+1,500
+50% +$160K 0.19% 78
2020
Q4 		$320K Buy
+2,983
New +$287K 0.17% 75

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harbor Advisory Corp's ABBV Position: Q2 2026 in Review

Harbor Advisory Corp reduced its AbbVie (ABBV) stake by 2.1% in Q2 2026, selling an estimated $74.2K and leaving 16,357 shares worth $4.12M. The position accounts for 1.1% of the portfolio, ranked #30.

Harbor Advisory Corp first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $5.07M in Q3 2025. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harbor Advisory Corp held 16,357 shares of AbbVie worth $4.12M as of Q2 2026.
  • Harbor Advisory Corp sold 345 AbbVie shares in Q2 2026, an estimated $74.2K.
  • AbbVie made up 1.1% of Harbor Advisory Corp's portfolio in Q2 2026, its #30 holding.
  • Harbor Advisory Corp first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Harbor Advisory Corp's AbbVie position peaked at $5.07M in Q3 2025.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harbor Advisory Corp's 13F filing for Q2 2026, filed 13 Aug 2026.